A recent National Academies of Sciences, Engineering, and Medicine report details several adverse impacts from poor diversity in clinical trials. These include lack of access to effective medical interventions, compounding of health disparities in underrepresented and excluded populations, and hindering innovation. Read the Full Article.
Home / Community / Lack of diversity in clinical trials costs billions of dollars. Incentives can spur innovation
Recent Posts
- NJ ACTS Clinical Research Coordination Badge October Cohort Now Open!
- Pocket Ultrasound Reduces Hospital Stays for Patients with Shortness of Breath.
- Researchers Find Medicaid Is Crucial to Access Treatment for Opioid Addiction.
- New Charts for Artery Stiffness Could Flag Heart Risk Long Before Symptoms.
- When It Comes to Breastfeeding, Study Shows Timing Is an Important Consideration.
Categories
- Community (2,342)
- Covid (991)
- CTO Events (6)
- News (2,978)
- Pilots (21)